Ira Jay Goldberg MD
Diabetes, Lipid Metabolism
Director, Division of Endocrinology, Diabetes, and Metabolism
Join to View Full Profile
530 1st AvenueSuite 5ENew York, NY 10016
Phone+1 212-481-1350
Dr. Goldberg is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
Harvard Medical SchoolClass of 1975
Massachusetts Institute of TechnologyB.S., 1971
Certifications & Licensure
NY State Medical License 1976 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014, 2016-2017
- Member Association of American Physicians, 1999
Publications & Presentations
PubMed
- The N-terminus of apolipoprotein B mediates the interaction of atherogenic lipoproteins with endothelial cells.Ainara G Cabodevilla, Camila Calistru, Waqas Younis, Dimitris Nasias, Tse Ww Ho
The Journal of Clinical Investigation. 2026-06-15 - Cardiac Lipid Metabolism: Cells, Metabolites, and Rhythms.Ira J Goldberg, Martin E Young, P Christian Schulze, Konstantinos Drosatos
Circulation Research. 2026-06-05 - Validation of Brachial Vein Endothelial Transcriptomics to Assess the Coronary Vasculature.Michael S Garshick, Florencia Schlamp, Isabelle Boothman, Tessa Barret, Filipp Kazatsker
Circulation Research. 2026-06-01
Journal Articles
- Myeloperoxidase: A Therapeutic Target for Preventing Insulin Resistance and the Metabolic Sequelae of Obesity?Heinecke JW, Goldberg IJ, Diabetes, 1/1/2014
- Cardiac Metabolic Compensation to Hypertension Requires Lipoprotein LipaseYamashita H, KG. Bharadwaj, S Ikeda, T-S Park, IJ Goldberg, A J Physio, Endo/Metab, 1/1/2008
- In vivo arterial lipoprotein lipase expression augments inflammatory responses and impairs vascular dilatationTakahashi M, M Yokoyama, Y Hiyama, Y Hu, K Melford, A Bensadoun, IJ Goldberg, ATVB, 1/1/2008
Books/Book Chapters
Lectures
- Diabetes and Hypertriglyceridemia: Cardiovascular Risk, Mechanisms, and Indications for TreatmentENDO 2019 - New Orleans, LA - 3/26/2019
- Hepatic Substrate Metabolism and Cardiometabolic DiseaseENDO 2018: 100th Endocrine Society Annual Meeting - Chicago, Illinios - 03/18/2018
- Endocrinology Board Review, Endocrinology SocietySan Francisco - 9/2/2014
Press Mentions
Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 3rd, 2024- Newfound Mechanism May Explain Why Some Cancer Treatments Boost Risk of Heart DiseaseDecember 2nd, 2024
- Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinars on Cardiometabolic Candidates ARO-APOC3 and ARO-ANG3November 4th, 2020
Grant Support
- Diabetes-Mediated Effects On Myeloid Precursors And Vascular ComplicationsNational Institute Of Diabetes And Digestive And Kidney Diseases2012
- Nutritional And Hormonal Pathways For Reduction Of Apob-LipoproteinsNational Heart, Lung, And Blood Institute2012
- Extracellular Regulation Of Lipoprotein Lipase ActivityNational Heart, Lung, And Blood Institute2010–2011
- Hyperglycemia, Aldose Reductase And Murine AtherosclerosisNational Heart, Lung, And Blood Institute2006–2010
- Creating Glucose Responsive Cardiovascular ComplicationsNational Heart, Lung, And Blood Institute2006–2010
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
